Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)

Flaxman A., Marchevsky N., Jenkin D., Aboagye J., Aley PK., Angus BJ., Belij-Rammerstorfer S., Bibi S., Bittaye M., Cappuccini F., Cicconi P., Clutterbuck E., Davies S., Dejnirattisai W., Dold C., Ewer K., Folegatti PM., Fowler J., Hill AVS., Kerridge S., Minassian AM., Mongkolspaya J., Farooq Mujadidi Y., Plested E., Ramasamy MN., Robinson H., Sanders H., Sheehan E., Smith H., Snape MD., Song R., Woods D., Screaton GR., Gilbert SC., Voysey M., Pollard A., Lambe T., Group TOCOVIDV.

DOI

10.2139/ssrn.3873839

Type

Preprint

Publication Date

29/06/2021

Permalink Original publication